Список литературы

1. Cohen P. et al. Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop//The Journal of Clinical Endocrinology & Metabolism. 2008. Vol. 93, N 11. P. 4210 - 4217.

2. Inzaghi E., Reiter E., Cianfarani S. The Challenge of Defining and Investigating the Causes of Idiopathic Short Stature and Finding an Effective Therapy//Horm. Res. Paediatr. 2019. Vol. 92, N 2. P. 71 - 83.

3. Wit J.M. et al. Idiopathic short stature: Definition, epidemiology, and diagnostic evaluation//Growth Hormone & IGF Research. 2008. Vol. 18, N 2. P. 89 - 110.

4. Воронцова М.В., Панкратова М.С. Молекулярно-генетические исследования при идиопатической низкорослости: 1//Проблемы Эндокринологии. 2012. Vol. 58, N 1. P. 45 - 53.

5. Ranke M.B. Towards a consensus on the definition of idiopathic short stature//Horm Res. - 1996. - T. 45 Suppl 2. - C. 64 - 6.

6. Lindsay R. et al. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency//The Journal of Pediatrics. 1994. Vol. 125, N 1. P. 29 - 35.

7. Федеральные клинические рекомендации (протоколы) по ведению детей с эндокринными заболеваниями. Под ред. Дедова И.И., Петерковой В.А. - Москва: Практика, 2014. - 442 с.

8. Витебская А.В. Антропометрические, гормональные, рентгенологические и молекулярно-генетические проявления идиопатической низкорослости у детей: дис. канд. мед. наук. Москва. 2003. - 152 с.

9. Детская эндокринология./Дедов И.И., Петеркова В.А. - Москва: Универсум Паблишинг, 2006. - 595 с.

10. Солтаханов Э.М. Семейная низкорослость: патогенез, оптимизация методов диагностики и лечения: дис. канд. мед. наук. Москва. 1996. - 267 с.

11. Шандин А.Н. Клинические варианты и молекулярные основы идиопатической низкорослости у детей: дис. канд. мед. наук. Москва. 2011. - 152 с.

12. Шандин А.Н., Нагаева Е.В., Петеркова В.А. и др. Эффективность и безопасность применения рекомбинантного гормона роста у детей с идиопатической низкорослостью//Проблемы Эндокринологии. 2010; 56(6): 14 - 23. https://doi.org/10.14341/probl201056614-23.

13. Нагаева Е.В., Ширяева Т.Ю., Петеркова В.А. и др. Российский национальный консенсус. Диагностика и лечение гипопитуитаризма у детей и подростков//Проблемы Эндокринологии. 2018; 64(6): 402 - 411. https://doi.org/10.14341/probl10091.

14. Rosenfeld R.G. The molecular basis of idiopathic short stature//Growth Hormone & IGF Research. 2005. Vol. 15. P. 3 - 5.

15. Шандин А.Н., Петеркова В.А. Классификация, диагностика и лечение идиопатической низкорослости. Проблемы Эндокринологии. 2009; 55(4): 36 - 44. https://doi.org/10.14341/probl200955436-44.

16. Hokken-Koelega A. C. Diagnostic workup of the short child//Horm Res Paediatr. - 2011. - T. 76 Suppl 3. - C. 6 - 9. https://doi.org/10.1159/000330136.

17. Ross J.L. et al. Psychological Adaptation in Children with Idiopathic Short Stature Treated with Growth Hormone or Placebo//The Journal of Clinical Endocrinology & Metabolism. 2004. Vol. 89, N 10. P. 4873 - 4878.

18. . et al. Quality of Life of Children and Adolescents with Short Stature: The Twofold Contribution of Physical Growth and Adaptive Height-Related Cognitive Beliefs//J Clin Psychol Med Settings. 2022. Vol. 29, N 2. P. 466 - 475.

19. Chen S.-K. Is Growth Hormone Treatment Associated With the Psychological Status in Children With Short Stature?//American Journal of Therapeutics. 2021. Vol. 28, N 3. P. 368.

20. Нагаева Е.В. Федеральные клинические рекомендации по диагностике и лечению гипопитуитаризма у детей и подростков. Проблемы Эндокринологии. 2013; 59(6): 27 - 43. https://doi.org/10.14341/probl201359627-43.

21. Rosenfeld R. G., Albertsson-Wikland K., Cassorla F., Frasier S. D., Hasegawa Y., Hintz R. L., Lafranchi S., Lippe B., Loriaux L., Melmed S., et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited//J Clin Endocrinol Metab. - 1995. - T. 80, N 5. - C. 1532 - 40.

22. , Hertel T. Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children//Horm Res. 2003. Vol. 60 Suppl 3. P. 65 - 70.

23. Ranke M.B. Treatment of children and adolescents with idiopathic short stature//Nat Rev Endocrinol. 2013. Vol. 9, N 6. P. 325 - 334.

24. Lawaetz J.G. et al. Evaluation of 451 Danish Boys With Delayed Puberty: Diagnostic Use of a New Puberty Nomogram and Effects of Oral Testosterone Therapy//The Journal of Clinical Endocrinology & Metabolism. 2015. Vol. 100, N 4. P. 1376 - 1385.

25. et al. Effects of levothyroxine on growth hormone (gh) sensitivity in children with idiopathic short stature//Growth Hormone & IGF Research. 2014. Vol. 24, N 4. P. 119 - 122.

26. Wang W., Jiang S., Cui Z., Luo X., Shi L., Zheng H. Sensitivity of supplementation of thyroid hormone on treatment of idiopathic short-stature children during therapy with recombinant human growth hormone//Front Med. - 2018. - T. 12, N 5. - C. 580 - 585. doi: 10.1007/s11684-017-0585-9.

27. Selva K. A., Buckway C. K., Sexton G., Pratt K. L., Tjoeng E., Guevara-Aguirre J., Rosenfeld R. G. Reproducibility in patterns of IGF generation with special reference to idiopathic short stature//Horm Res. - 2003. - T. 60, N 5. - C. 237 - 46. doi: 10.1159/000074038.

28. Blair J.C. et al. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature//Clinical Endocrinology. 2004. Vol. 60, N 2. P. 163 - 168.

29. et al. Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and Puberty. J Clin Endocrinol Metab. 2001 Dec; 86(12): 5870 - 6..

30. Rahmati S., Pourattar N., Azami M., Depisheh A., Najafi R., Sayehmiri K. The Effect of Growth Hormone Treatment on Adult Height of Children with Idiopathic Short Stature: a systematic review and Meta-analyses//Endocrinol Metab. - 2017. - T. 7, N 2. - C. 45 - 54.

31. Deodati A., Cianfarani S. Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review//Bmj. - 2011. - T. 342. - C. c7157. doi: https://doi.org/10.1136/bmj.c7157 [Electronic resource]. URL: https://www.bmj.com/content/342/bmj.c7157.long (accessed: 28.06.2024).

32. Rekers-Mombarg L. T., Massa G. G., Wit J. M., Matranga A. M., Buckler J. M., Butenandt O., Chaussain J. L., Frisch H., Leiberman E., Yturriaga R., Aarskog D., Chatelain P. G., Colle M., Dacou-Voutetakis C., Delemarre-van de Waal H. A., Girard F., Gosen J. J., Irle U., Jansen M., Jean R., Job J. C., Kaar M. L., Kollemann F., Lenko H. L., Waelkens J. J., et al. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators//J Pediatr. - 1998. - T. 132, N 3 Pt 1. - C. 455 - 60.

33. Kamp G.A. et al. High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature//Archives of Disease in Childhood. BMJ Publishing Group Ltd, 2002. Vol. 87, N 3. P. 215-220.

34. Mankin H. J., Jupiter J., Trahan C. A. Hand and foot abnormalities associated with genetic diseases//Hand (N Y). - 2011. - T. 6, N 1. - C. 18 - 26. doi: 10.1007/s11552-010-9302-8.

35. Khawaja N., Owaineh H., Batieha A., Frahid O., El-Khateeb M., Ajlouni K. M. The Effect of Gonadotropin-Releasing Hormone Analogue on Final Adult Height in Children with Idiopathic Short Stature//Med Princ Pract. - 2019. - T. 28, N 6. - C. 509 - 516. doi: 10.1159/000499929.

36. Wit J.M. et al. Idiopathic short stature: Management and growth hormone treatment//Growth Hormone & IGF Research. 2008. Vol. 18, N 2. P. 111 - 135.

37. Tanaka T. Sufficiently long-term treatment with combined growth hormone and gonadotropin-releasing hormone analog can improve adult height in short children with isolated growth hormone deficiency (GHD) and in non-GHD short children//Pediatr Endocrinol Rev. - 2007. - T. 5, N 1. - C. 471 - 81.

38. Bryant J., Baxter L., Cave C. B., Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents//Cochrane Database Syst Rev. - 2007.10.1002/14651858.CD004440.pub2 N 3. - C. Cd004440.

39. Grimberg A., DiVall S. A., Polychronakos C., Allen D. B., Cohen L. E., Quintos J. B., Rossi W. C., Feudtner C., Murad M. H. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency//Horm Res Paediatr. - 2016. - T. 86, N 6. - C. 361 - 397. doi: 10.1159/000452150.

40. , Kocaay P., , , , . The Effect of Recombinant Growth Hormone Treatment in Children with Idiopathic Short Stature and Low Insulin-Like Growth Factor-1 Levels//J Clin Res Pediatr Endocrinol. - 2015. - T. 7, N 4. - C. 301-6. doi: 10.4274/jcrpe.2111.

41. Cohen P. et al. Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels//Clinical Endocrinology. 2013. Vol. 78, N 3. P. 405 - 414.

42. Kamp G.A. et al. A Randomized Controlled Trial of Three Years Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Children with Idiopathic Short Stature and Intrauterine Growth Retardation. 2001. Vol. 86, N 7.

43. Karamizadeh Z., Kashef M. A., Jalaeian H., Namazee N. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran//Kaohsiung J Med Sci. - 2006. - T. 22, N 4. - C. 161 - 5. doi: 10.1016/S1607-551X(09)70301-8.

44. Van Gool S.A. et al. Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty//The Journal of Clinical Endocrinology & Metabolism. 2007. Vol. 92, N 4. P. 1402 - 1408.

45. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium//Horm Res Paediatr. - 2019. - T. 91, N 6. - C. 357 - 372.

46. Mauras N. et al. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature//The Journal of Clinical Endocrinology & Metabolism. 2016. Vol. 101, N 12. P. 4984 - 4993.

47. McGrath N., O'Grady M.J. Aromatase inhibitors for short stature in male children and adolescents//Cochrane Database of Systematic Reviews. 2015. Vol. 2015, N 10.

48. Luca F.D. et al. Management of Puberty in Constitutional Delay of Growth and Puberty//Journal of Pediatric Endocrinology and Metabolism. De Gruyter, 2001. Vol. 14, N s2. P. 953 - 958.

49. M.K. Gupta, D.C. Brown, C. Faiman, C.J. Kelnar, F.C. Wu. Effect of low-dose testosterone treatment on androgen regulated proteins prostate specific antigen and sex hormone binding globulin in short prepubertal boys: lack of initiation of puberty J. Pediatr. Endocrinol. Metab., 16 (2003), pp. 55 - 62.

50. Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment. J Pediatr Endocrinol Metab. 2021 Jul 22; 34(10): 1263 - 1271. doi: 10.1515/jpem-2021-0389.

51. Witkowska-Sedek E. et al. Evaluation of glucose metabolism in children with growth hormone deficiency during long-term growth hormone treatment//J Physiol Pharmacol. 2018. Vol. 69, N 2.

52. Malozowski S. et al. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone//J Pediatr. 1995. Vol. 126, N 6. P. 996 - 999.

53. Dauber A., Jorge A. A. L., Nilsson O., Dekkers O. M., Argente J., Netchine I. et al. International guideline on genetic testing of children with short stature//European Journal of Endocrinology. - 2026. - Vol. 194. - N 2. - P. R17 - R36. DOI: 10.1093/ejendo/lvag013.

54. W. W. Greulich and S. I. Pyle: Radiographic atlas of skeletal development of the hand and wrist. 2nd edition. I volume-atlante di 256 pagine. Stanford University Press, Stanford, California, 1959.

55. Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых (Принят на 42-й научной сессии Центрального научно-исследовательского института 52 гастроэнтерологии; Москва, 2 - 3 марта 2016 г.) Парфенов А.И., Маев И.В., Баранов А.А. и др.//Альманах клинической медицины. - 2016. - Том 44, N 6. - С. 661 - 88. doi:10.18786/2072-0505-2016-44-6661-688.

56. Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, Mulder CJ, Lundin KEA. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterology Journal 2019, Vol. 7(5) 583 - 613 DOI: 10.1177/2050640619844125 journals.sagepub.com/home/ueg.

57. Husby S, Koletzko S, , Kurppa K, Mearin ML, Ribes-Koninckx C, Shamir R, Troncone R, Auricchio R, Castillejo G, Christensen R, Dolinsek J, Gillett P, , Koltai T, Maki M, Nielsen SM, Popp A, , Werkstetter K, Wessels M. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020 Jan; 70(1): 141 - 156.

58. Cataldo F, Lio D, Marino V, et al. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 2000; 47:366-9.

59. Mearin ML, Agardh D, Antunes H, Al-Toma A, Auricchio R, Castillejo G, Catassi C, Ciacci C, Discepolo V, Dolinsek J, Donat E, Gillett P, Guandalini S, Husby Md DMSc S, Koletzko Md S, Koltai T, , Kurppa K, Lionetti E, , Martinez Ojinaga E, Meijer C, Monachesi C, Polanco I, Popp A, Roca M, Rodriguez-Herrera A, Shamir R, Stordal K, Troncone R, Valitutti F, Vreugdenhil A, Wessels M, Whiting P; ESPGHAN Special Interest Group on Celiac Disease. ESPGHAN Position Paper on Management and Follow-up of Children and Adolescents With Celiac Disease. J Pediatr Gastroenterol Nutr. 2022 Sep 1; 75(3): 369 - 386. doi: 10.1097/MPG.0000000000003540. Epub 2022 Jun 27. PMID: 3575852.